Including nonrandomized evidence in living systematic reviews: lessons learned from the COVID-NMA initiative
Open Access
- 21 November 2025
- journal article
- review article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 190, 112071
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- Horizon 2020 Framework Programme (101037867)
- Institut National de la Santé et de la Recherche Médicale
- Ministère des Solidarités et de la Santé
- Centre National de la Recherche Scientifique
- Assistance Publique - Hôpitaux de Paris
- Agence Nationale de la Recherche
- Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation
- Université de Paris
This publication has 21 references indexed in Scilit:
- Transparent Reporting of Observational Studies Emulating a Target Trial—The TARGET StatementJAMA, 2025
- metaCOVID: A web‐application for living meta‐analyses of COVID‐19 trialsResearch Synthesis Methods, 2023
- The Lancet Commission on lessons for the future from the COVID-19 pandemicThe Lancet, 2022
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational studyThe Lancet, 2021
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort studyThe Lancet, 2021
- Secondary electronic sources demonstrated very good sensitivity for identifying studies evaluating interventions for COVID-19Journal of Clinical Epidemiology, 2021
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectivenessThe Lancet, 2021
- Day-to-day discovery of preprint–publication linksScientometrics, 2021
- Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystemJournal of Clinical Epidemiology, 2020
- Living systematic review: 1. Introduction—the why, what, when, and howJournal of Clinical Epidemiology, 2017